CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75.2% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Novavax NVAX

Sell
 Buy

Novavax live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Novavax news

N/A
Emma Rose 2025 Jul 03, 08:35

US Economy on Stagflation Watch: Apollo Global Management's Outlook

N/A
Ava Grace 2025 Jul 03, 08:35

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

N/A
Sophia Claire 2025 Jul 03, 07:35

S&P 500 Earnings Season to Test Rally Amidst Dim Outlook

2021 May 11, 13:20

US pre-market: selling unabated

2021 May 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 May 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Latest news

Show more
Tommy Yap 2025 Jul 07, 16:00

Morning Note: RBA Holds Rates; Trump Tariffs Hit; Tesla Dips on Musk News

Morning Note Stocks Central Banks
Frances Wang 2025 Jul 06, 16:00

Stock market today: Dow, S&P 500, Nasdaq futures fall, Sensex, Nifty update

Stocks Indices
Frances Wang 2025 Jul 06, 16:00

Lumber Stocks to Watch: SSD stock, UFPI stock, HD stock

Stocks
Frances Wang 2025 Jul 06, 16:00

Oil Price Is Under $70: Where is Oil Price Expected to Go?

Commodities
Tommy Yap 2025 Jul 06, 16:00

Morning Note: Dollar Near Lows on Tariffs; US Eyes AI Chip Curbs; Ethereum’s Future

Morning Note Forex Cryptocurrencies
monetary Policy
Tommy Yap 2025 Jul 05, 21:00

Week Ahead: Monetary Policy Focus Turns to RBA and RBNZ

Forex Indices
Ghko B 2025 Jul 03, 16:00

Solana Price Gains 4%: What is the price target for Solana?

Cryptocurrencies
Frances Wang 2025 Jul 03, 16:00

Bitcoin Price Outlook: What will be the value of Bitcoin in 2025?

Cryptocurrencies

Info

Spread

0.05

Spread (%)

0.7123 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1101397888

Shares Outstanding

161970000

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

2.75

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Jul 07, 16:00

MCD Stock Analysis: What’s Going on with McDonald's Corporation?

Shares Stocks
Ghko B 2025 Jul 07, 16:00

Biotech Stock Analysis: MBIO Soars after FDA Grants Orphan Drug Designation

Stocks
Ghko B 2025 Jul 07, 16:00

Dow Sheds More Than 400 Points: Why Is the Stock Market Down Today?

Stocks
Trustpilot